Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Core genes (PDB ID)</td><td class="align_center">Active ingredients</td><td class="align_center">Binding energy (kcal/mol)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">TNF (3GWT)</td><td class="align_center">Quercetin</td><td class="align_center">-9.1</td></tr><tr><td class="align_left">CXCL8 (5D14)</td><td class="align_center">Quercetin</td><td class="align_center">-7.9</td></tr><tr><td class="align_left">IL-1B (5R8A)</td><td class="align_center">Quercetin</td><td class="align_center">-7.6</td></tr><tr><td class="align_left">IL6 (1IL6)</td><td class="align_center">Quercetin</td><td class="align_center">-7.4</td></tr><tr><td class="align_left">MMP9 (6ESM)</td><td class="align_center">Luteolin</td><td class="align_center">-10.8</td></tr><tr><td class="align_left">TNF (3GWT)</td><td class="align_center">Kaempferol</td><td class="align_center">-9.1</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Screening docking results between receptors and ligands.</div>

BioMed Research International

tab3

Table 3

Table 3: Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology 

Table 3 | Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology 